U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 6, 2004
-----------
INTERNATIONAL BIOCHEMICAL INDUSTRIES, INC.
------------------------------------------
(Exact name of registrant as specified in its charter)
Georgia
---------------------------------------
(State or jurisdiction of incorporation
or organization)
0-24913
-----------------------
(Commission File Number
58-2181628
--------------------------------------
(I.R.S. Employer Identification Number
120 South Houghton Road, Suite #138-308, Tucson, Arizona 85748
--------------------------------------------------------------
(Address of principal executive offices)
Registrant's telephone number: (520) 844-1005
--------------
-------------------------------------------------------------
(Former name or former address, if changed since last report)
ITEM 5. OTHER EVENTS.
AND
ITEM 9. REGULATION FD DISCLOSURE.
(a) Immediately after the filing of this Form 8-K on this date, Milo
Bergeson will resign as President and Chief Executive Officer of the Registrant,
and Gary Wagnon will resign as Secretary/Treasurer of the Registrant. All
directors of the Registrant had previously resigned on January 17, 2004 (as
reported in a Form 8-K filed on January 28, 2004).
(b) It has come to the attention of the Registrant that that the United
States Attorney's Office is conducting a grand jury investigation. The
investigation relates to a series of press releases issued by the registrant in
early 2003.
SIGNATURE
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
INTERNATIONAL BIOCHEMICAL INDUSTRIES, INC.
Dated: May 6, 2004 By: /s/ Milo Bergeson
-----------------
Milo Bergeson, President/CEO